HRTS Stock Overview
An exchange traded fund launched and managed by Tema Global Limited.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Tema ETF Trust - Tema GLP-1, Obesity & Cardiometabolic ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$35.20 |
| 52 Week High | US$36.03 |
| 52 Week Low | US$26.26 |
| Beta | 0 |
| 11 Month Change | 2.77% |
| 3 Month Change | 10.28% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 32.21% |
Recent News & Updates
Shareholder Returns
| HRTS | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0.3% | 1.7% | 0.3% |
| 1Y | n/a | 31.5% | 22.2% |
Return vs Industry: Insufficient data to determine how HRTS performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how HRTS performed against the US Market.
Price Volatility
| HRTS volatility | |
|---|---|
| HRTS Average Weekly Movement | 2.7% |
| Capital Markets Industry Average Movement | 4.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HRTS has not had significant price volatility in the past 3 months.
Volatility Over Time: HRTS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | n/a | n/a | temaetfs.com/hrts |
Tema ETF Trust - Tema GLP-1, Obesity & Cardiometabolic ETF is an exchange traded fund launched and managed by Tema Global Limited. The fund is co-managed by NEOS Investment Management, LLC. It invests in public equity markets of global region.
Tema ETF Trust - Tema GLP-1, Obesity & Cardiometabolic ETF Fundamentals Summary
| HRTS fundamental statistics | |
|---|---|
| Market cap | US$87.67m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs HRTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HRTS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HRTS perform over the long term?
See historical performance and comparison